/24-7PressRelease/ - MONROVIA, CA, June 20, 2008 - Michele Pontinen, Senior Manager of Life Sciences at Capgemini LLC will be speaking at GTCbio's Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. Ms. Pontinen will give a presentation entitled "Forget About the Boulders - I'm Interested in Mining for the Diamonds!" Data Mining (And Other Capabilities) Made Possible by Clinical IT - a Real Life Industrialized Model."
Data mining has always been important to Capgemini's industry. Having the ability to mine across pre-clinical, Phase I-III research trials and marketing studies as well as other external data has always been the goal. To date, data and systems 'interoperability' has been one of the major challenges to this effort. In Capgemini's current state, they are able, albeit infrequently, to cull-out major safety and efficacy information (the boulders). Ms. Pontinen and her colleagues are hampered, however, in mining for those diamonds that can give them more accurate and focused insight into product extensions, safety information and treatment. This presentation will discuss a current solution they have 'industrialized' for a client. The solution includes a repository for mining across data in an interoperable formatting, using industry standards available to them today, the toolset used to migrate closed studies (studies reported to authorities) and convert in-live (on-going trials) to a new EDC platform with pass through to the repository. Ms. Pontinen will present the challenges and pitfalls to enabling this functionality and discuss how Clinical IT Operations can make this model successful and drive the right solution for the business owners and for operations. Ms. Pontinen will define what 'interoperable' means for systems and data, provide insight into the challenges of driving this solution, explain how Capgemini 'industrialized' the process, and present other benefits in addition to data mining capability.
The Global Clinical Trial Operations conference brings together leaders, directors, vice presidents, heads, managers, supervisors, and CROs from all over the world to collaborate and discuss the latest developments in clinical trial operations and logistics and covers clinical trials in emerging markets, first-in-man clinical trials, pediatric clinical trials, material storage, distribution, site selection, patient recruitment and retention, technology in clinical trials and case studies of running global clinical trials.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://gtcbio.com/conferenceDetails.aspx?id=127.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
# # #
Read more Press Releases from Rania Hafez:- De Yang from the National Cancer Institute to Speak at the 7th Cytokines & Inflammation Conference
- Gregory A. Bonfiglio, Managing Partner at Proteus Venture Partners to Give Featured Presentation at 5th Stem Cell Research & Therapeutics Conference
- Charles Peterfy, Chief Scientific Officer at Synarc to Give Featured Presentation at GTCbio's 4th Imaging in Preclinical & Clinical Drug Development Conference
- Michael Karin, Professor at UCSD to Give Keynote Speech at 7th Cytokines & Inflammation Conference
- GTCbio Announces its 7th Annual Cytokines & Inflammation Conference
- Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center to Give Keynote Speech at GTCbio's 2nd Oncology Biomarkers Conference on January 19-20 in Miami, Florida
- GTCbio Announces its 2nd Annual Oncology Biomarkers Conference
- Michael Shih, Director of Business Development at Eisai Inc. and Deepa Talpade, Director of Global Licensing & Strategic Alliances at Schering Plough to Give Joint Featured Presentation at GTCbio's CNS Diseases Partnering & Deal-Making Summit on Dec. 1-2, 2008 in Boston, MA
- GTCBIO ANNOUNCES ITS INAUGURAL CNS DISEASES PARTNERING & DEAL-MAKING SUMMIT
- Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 - San Diego, CA)
